Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by GenericAdvocateon Mar 24, 2017 11:52am
92 Views
Post# 26026242

RE:$50 price target

RE:$50 price target

suitman, This site

https://www.rttnews.com/corpinfo/fdacalendar.aspx 

gives you drugs in the cue for fda approval.  As you can see cxrx has nothing.

FDA also has a similar site if you wanted to double check what I posted earlier today.  For repacks and reformulations, they never announce it in a PR  -- that is why we haven't seen "new launches" being announced.  Going from a 150 mg tablet to a 175 mg tablet..  well technically its a new pill but no one gets excited about it.  
<< Previous
Bullboard Posts
Next >>